Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZBIO · against 381 other Healthcare companies of similar size
Ranked #369 of 382 · scores higher than 3% of peers
Bars: peers in each 10-point band of the growth score29 peers with a growth score of 0–9, including ZBIO · Click a bar to see the companies
Mainly because of its revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
| Metric | ZBIO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 384 reported | -93.3% | 6.1% | 1% | 33% | |
| Earnings per share growthHigher is better · 216 reported | Not reported | 8.1% | — | — | 33% |
| 3-year revenue growthHigher is better · 374 reported | Not reported | 7.1% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 365 | 17.6B CNY (≈$2.5B) | 5 | 11 | |
| 365 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 1.7B USD |
| 5 |
| 23 |
| 365 | 952M USD | 5 | 3 |
| 369 | 12.8B CNY (≈$1.8B) | 4 | 44 |
| 369 | 1.8B USD | 4 | 23 |
| 371 | 143.9B JPY (≈$978M) | 3 | 26 |
| 371 | 1.1B USD | 3 | 26 |
| 371 | 2.3B USD | 3 | 26 |
| 371 | 2.2B USD | 3 | 20 |